All Stories

  1. The novel nonapeptide acein targets angiotensin converting enzyme in the brain and induces dopamine release
  2. Environnement précoce et vulnérabilité neuropsychiatrique
  3. Impact of the gut microbiota on the neuroendocrine and behavioural responses to stress in rodents
  4. Absence of the gut microbiota enhances anxiety-like behavior and neuroendocrine response to acute stress in rats
  5. The dopamine D1 receptor agonist SKF 38393 improves temporal order memory performance in maternally deprived rats
  6. Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation
  7. Possible involvement of endocannabinoids in the increase of morphine consumption in maternally deprived rat
  8. Preclinical Animal Studies
  9. Maternal deprivation induces deficits in temporal memory and cognitive flexibility and exaggerates synaptic plasticity in the rat medial prefrontal cortex
  10. Early stress leads to effects on estrous cycle and differential responses to stress
  11. Leucine and citrulline modulate muscle function in malnourished aged rats
  12. Maternal deprivation induces depressive-like behaviours only in female rats
  13. Adolescent Exposure to Chronic Delta-9-Tetrahydrocannabinol Blocks Opiate Dependence in Maternally Deprived Rats
  14. The CCK2 agonist BC-264 decreases predatory fear freezing at high but not low dosages in PVG hooded rats during initial exposure to a cat
  15. Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats
  16. Brief early handling increases morphine dependence in adult rats
  17. Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365,260
  18. Ornithine α-ketoglutarate supplementation influences motor activity in healthy rats
  19. Alpha-lactalbumin-enriched diets enhance serotonin release and induce anxiolytic and rewarding effects in the rat
  20. Impact neurobiologique de la séparation mère/nouveau-né chez le rongeur
  21. The Dual Peptidase Inhibitor RB101 Induces a Long-Lasting Increase in the Extracellular Level of Met-Enkephalin-Like Material in the Nucleus Accumbens of Freely Moving Rats
  22. Behavioral responses to ingestion of different sources of fat. Involvement of serotonin?
  23. The entorhinal cortex-nucleus accumbens pathway and latent inhibition: A behavioral and neurochemical study in rats.
  24. The entorhinal cortex-nucleus accumbens pathway and latent inhibition: A behavioral and neurochemical study in rats.
  25. Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine
  26. Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect
  27. Leptin decreases feeding and exploratory behaviour via interactions with CCK1 receptors in the rat
  28. Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the ∂ opioid system in the nucleus accumbens of rat
  29. CCK in Anxiety and Cognitive Processes
  30. Opposite effects of CCKB agonists in grooming behaviour in rats: further evidence for two CCKB subsites
  31. Development of new potent agonists able to interact with two postulated subsites of the cholecystokinin CCK-B receptor
  32. The CCK-B Agonist, BC264, Increases Dopamine in the Nucleus Accumbens and Facilitates Motivation and Attention After lntraperitoneal Injection in Rats
  33. Opioid and CCK Systems in Anxiety and Reward
  34. Activation of CCKB receptors by BC264 increases extracellular levels of metenkephalin and dopamine in the nucleus accumbens: A microdialysis studies in awake rats
  35. Different modifications of the dopamine metabolism in the core and shell parts of the nucleus accumbens following CCK-A receptor stimulation in the shell region
  36. Structure-based design and pharmacological properties of potent selective and systemically active CCK-B peptidomimetics
  37. Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation
  38. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of δ-opioid receptors
  39. Use of μ and δ opioid peptides of various selectivity gives further evidence of specific involvement of μ opioid receptors in supraspinal analgesia (tail-flick test)
  40. Synthesis and biological activity of Boc [Nle28, Nle31]CCK27–33, a highly potent CCK8 analogue
  41. Aminopeptidase A: Selective inhibition and physiological involvment in CCK8 metabolism